Dafou, D.; Kanata, E.; Pettas, S.; Bekas, N.; Dimitriadis, A.; Kempapidou, G.; Lagoudaki, R.; Theotokis, P.; Touloumi, O.; Delivanoglou, N.;
et al. RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE). Cells 2022, 11, 3582.
https://doi.org/10.3390/cells11223582
AMA Style
Dafou D, Kanata E, Pettas S, Bekas N, Dimitriadis A, Kempapidou G, Lagoudaki R, Theotokis P, Touloumi O, Delivanoglou N,
et al. RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE). Cells. 2022; 11(22):3582.
https://doi.org/10.3390/cells11223582
Chicago/Turabian Style
Dafou, Dimitra, Eirini Kanata, Spyros Pettas, Nikolaos Bekas, Athanasios Dimitriadis, Garyfalia Kempapidou, Roza Lagoudaki, Paschalis Theotokis, Olga Touloumi, Nikoleta Delivanoglou,
and et al. 2022. "RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)" Cells 11, no. 22: 3582.
https://doi.org/10.3390/cells11223582
APA Style
Dafou, D., Kanata, E., Pettas, S., Bekas, N., Dimitriadis, A., Kempapidou, G., Lagoudaki, R., Theotokis, P., Touloumi, O., Delivanoglou, N., Kesidou, E., Xanthopoulos, K., Grigoriadis, N., Papavasiliou, F. N., & Sklaviadis, T.
(2022). RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE). Cells, 11(22), 3582.
https://doi.org/10.3390/cells11223582